Cargando…
Optogenetic Control of Engrafted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Live Mice: A Proof-of-Concept Study
Background: Cellular transplantation has emerged as promising approach for treating cardiac diseases. However, a poor engraftment rate limits our understanding on how transplanted cardiomyocytes contribute to cardiac function in the recipient’s heart. Methods: The CRISPR/Cas9 technique was employed...
Autores principales: | Joshi, Jyotsna, Xu, Bing, Rubart, Michael, Chang, Yun, Bao, Xiaoping, Chaliki, Hari P., Scott, Luis R., Zhu, Wuqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946017/ https://www.ncbi.nlm.nih.gov/pubmed/35326403 http://dx.doi.org/10.3390/cells11060951 |
Ejemplares similares
-
Optogenetics: Background, Methodological Advances and Potential Applications for Cardiovascular Research and Medicine
por: Joshi, Jyotsna, et al.
Publicado: (2020) -
Cardiac Engraftment of Genetically-Selected Parthenogenetic Stem Cell-Derived Cardiomyocytes
por: Yang, Tao, et al.
Publicado: (2015) -
Utilization of Human Induced Pluripotent Stem Cells for Cardiac Repair
por: Fan, Chengming, et al.
Publicado: (2020) -
Optogenetic‐mediated cardiovascular differentiation and patterning of human pluripotent stem cells
por: Hellwarth, Peter B., et al.
Publicado: (2021) -
Natural killer cells impede the engraftment of cardiomyocytes derived from induced pluripotent stem cells in syngeneic mouse model
por: Nakamura, Yuki, et al.
Publicado: (2019)